Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

A new mutation in the TRPS1 gene caused Trichorhinophalangeal syndrome in a 17-year-old, highlighting the need for genetic testing.

Lgr6+ cells are important for tissue repair and could be a target for treating cancer and other diseases.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

LSD1 is essential for healthy skin development and creating the skin's protective barrier.

The B2 genes are crucial for hair growth in rats.

Low-level laser therapy can stimulate hair growth and increase hair density, making it a promising treatment for hair loss.

Adding a second method to PROTACs could improve cancer treatment.

TBX3 gene affects pigmentation and marking formation in Dun Mongolian horses.

β‐thymosins, especially thymosin β4, help in heart protection, wound healing, and hair growth by stabilizing actin in cells.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Low-level laser therapy may help hair growth, but more research is needed.

Polycaprolactone and barium titanate composites show promise for use in biomedical applications.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

FLCN helps control iron levels in cells.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

The protein called small nuclear ribonucleoprotein polypeptide E is identified as a cause of a type of hair loss without other symptoms.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

PRP injections may slightly improve testicular development in male lambs.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

A synthetic octapeptide may help promote hair growth and counteract hair loss.